triprolidine (Actidil) Report issue

Small molecule Approved FDA
ChEMBL DrugBank Drug Central Drugs@FDA PubChem repoDB

Active Ingredient History

NOW
  • Now
Triprolidine is a first generation histamine H1 antagonist, which in combination with codeine phosphate and pseudoephedrine hydrochloride is sold under brand name TRIACIN-C. TRIACIN-C is indicated for temporary relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold.   NCATS

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Missing data
  • Pro Drug: No

Combination drugs

( codeine (Phenergan), pseudoephedrine (Benylin), triprolidine (Actidil) )
|
( pseudoephedrine (Benylin), triprolidine (Actidil) - other names: allerfe, corphe, histafe, myfe, trilitron )

Alternative names

actahist | actidil | allerfed | corphed | histafed | myfed | myidyl | pro-actidil | trilitron | triphed | tripolidina | triprolidin | triprolidine | triprolidine hcl | triprolidine hydrochloride | triprolidinum | tripyrolidine

Organizations (20)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (20)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (2)


 

Common Cold (approved 1985)

Hypersensitivity (approved 1985)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue